IT vs TVTX · P/E 16, rev $6.27B vs rev $233.2M
Gartner Inc (IT) versus Travere Therapeutics Inc (TVTX) — a side-by-side from cached financials, not a winner call.
Gartner Inc (IT) is a information technology services company listed on US.
Travere Therapeutics Inc (TVTX) is a biotechnology company listed on US.
Latest reported IT revenue for 2024-12-31 was $6.27B. Net income was $1.25B. Revenue was up 6.1% from 2023-12-31 to 2024-12-31. IT currently screens at market cap $11.03B and trailing P/E 16.3.
Latest reported TVTX revenue for 2024-12-31 was $233.2M. Net income was -$321.5M. Revenue was up 417.5% from 2023-12-31 to 2024-12-31. TVTX currently screens at market cap $1.33B.
IT currently screens at market cap $11.03B and trailing P/E 16.3. TVTX currently screens at market cap $1.33B.
Not investment advice. Open the IT and TVTX stock pages for the full models.
Not investment advice.